News

Parsing the pathology of prostate cancer

AI-guided pathology analysis can help predict immunotherapy response in rare cancers

Uncovering gene-based clues to how disrupted healing in stomach cells increases cancer risk

TIM-3 checkpoint blockade enhances CAR-T activity against solid tumours

Study reveals how leukaemia cells enter and damage lungs

PLXNC1 – a novel biomarker for consensus molecular subtype 4 in colorectal cancer (CMS4 CRC)

New laboratory tool opens door to better treatments for rare and deadly melanomas

Abnormally long mitochondria leak RNA: activating anti-tumour immunity

A new approach in cancer medicine: development of a novel “degraders” for the selective elimination of cancer cells

Low grip strength should not be used as an independent predictor of prostate cancer in older men

Researchers' new approach boosts immune response against lung cancer

Rare but real: Why a common skin cancer can hide on a finger